XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,900,286 | -56.2% | 143,451 | -50.6% | 0.06% | -57.1% |
| Q2 2023 | $11,180,400 | -25.6% | 290,400 | -30.9% | 0.13% | -35.1% |
| Q1 2023 | $15,032,838 | +27.7% | 420,029 | +40.7% | 0.20% | +30.6% |
| Q4 2022 | $11,767,489 | -19.4% | 298,440 | -26.2% | 0.16% | -23.0% |
| Q3 2022 | $14,597,000 | +109.6% | 404,359 | +76.6% | 0.20% | +90.7% |
| Q2 2022 | $6,964,000 | +127.9% | 228,928 | +14.5% | 0.11% | +114.0% |
| Q3 2021 | $3,056,000 | – | 199,984 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |